Login to Your Account

$100M In Private Funds Expected To Expand Neurogen's Portfolio

By Karen Pihl-Carey

Monday, March 22, 2004
Neurogen Corp.'s stock rose on Friday, following news that the company entered an agreement to privately sell $100 million worth of common shares. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription